Literature DB >> 8871858

Laser in situ keratomileusis to correct myopia of -6.00 to -29.00 diopters.

M C Knorz1, A Liermann, V Seiberth, H Steiner, B Wiesinger.   

Abstract

BACKGROUND: Photorefractive keratectomy can cause corneal scarring and visual loss in highly myopic eyes. We evaluated laser in situ keratomileusis (LASIK) because it has the theoretical advantage of preserving both the corneal epithelium and Bowman's layer.
METHODS: In a prospective study, LASIK was performed in 62 myopic eyes (42 patients) using the Automatic Corneal Shaper (Chiron Vision) and the Keracor 116 excimer laser (Chiron Technolas). We measured refraction and visual acuity, and evaluated corneal topography (TMS 1) and corneal clarity after 4 to 8 weeks and 4 to 6 months.
RESULTS: Four- to 6-month follow up was completed in 51 eyes. The mean preoperative spherical equivalent refraction was -14.80 diopters (D) (range, -6.00 to -29.00 D). Postoperatively, the mean deviation from the target refraction was -1.70 D (range, -9.00 to +2.50 D) at 4 to 8 weeks and -1.90 D (range, -9.50 to +2.25 D) at 4 to 6 months. At 4 to 6 months, 19 eyes (37%) were within +/- 0.50 D of the target refraction, 24 (47%) within +/- 1.00 D, 33 (65%) within +/- 2.00 D, and 40 (78%) within +/- 3.00 D. From 4 to 8 weeks to 4 to 6 months, the mean regression of myopia was -0.20 D (0.50 D or less in 24 eyes [47%], 1.00 D or less in 32 [63%], and 2.00 D or less in 42 [82%]). In six eyes (12%), the stromal interface was not visible, in 38 (74%) it was barely visible, and in seven (14%) it was clearly visible. Corneal topography revealed only small variations in clear-zone size and dioptric value, demonstrating a very stable correction 4 to 6 months postoperatively.
CONCLUSIONS: LASIK may be a safe and effective procedure to correct high myopia. Further research is required to develop satisfactory microkeratome technology, effective laser algorithms, and to determine long-term stability of refraction.

Entities:  

Mesh:

Year:  1996        PMID: 8871858     DOI: 10.3928/1081-597X-19960701-09

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  14 in total

Review 1.  Excimer laser refractive surgery.

Authors:  E E Manche; J D Carr; W W Haw; P S Hersh
Journal:  West J Med       Date:  1998-07

2.  Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group.

Authors:  R F Steinert; P S Hersh
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  The role of ultraviolet-B in corneal healing following excimer laser in situ keratomileusis.

Authors:  Zoltán Zsolt Nagy; Jeannette Tóth; Attila Nagymihály; Ildikó Süveges
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

4.  Assessment of ocular hemodynamics after laser in situ keratomileusis using color Doppler imaging.

Authors:  Waleed Abou Samra; Waleed Abu Samera; Maha Shahin; Hatem El-Awady; Ashraf Abd El-Rahman; Nahed El-Toukhy
Journal:  Int Ophthalmol       Date:  2013-06-07       Impact factor: 2.031

5.  3-Year follow-up after Lasik: assessing the risk factors for retreatment.

Authors:  Jorge E Valdez-García; Julio C Hernandez-Camarena; Rosa Martínez-Muñoz
Journal:  Int Ophthalmol       Date:  2015-05-19       Impact factor: 2.031

6.  Antiglaucoma drugs for achieving monovision after laser in situ keratomileusis.

Authors:  Kazutaka Kamiya; Kimiya Shimizu
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Intraoperative flap complications in laser in situ keratomileusis with two types of microkeratomes.

Authors:  Hani S Al-Mezaine; Saleh A Al-Amro; Saleh Al-Obeidan
Journal:  Saudi J Ophthalmol       Date:  2011-04-23

8.  Outcome of posterior chamber phakic intraocular lens procedure to correct myopia.

Authors:  Nasser Al Sabaani; Abdullah Al Assiri; Abdullah Al Torbak; Saeed Al Motawa
Journal:  Saudi J Ophthalmol       Date:  2013-07-01

9.  A prospective, randomized, fellow eye comparison of WaveLight® Allegretto Wave ® Eye-Q versus VISX CustomVue™ STAR S4 IR™ in laser in situ keratomileusis (LASIK): analysis of visual outcomes and higher order aberrations.

Authors:  Majid Moshirfar; Brent S Betts; Daniel S Churgin; Maylon Hsu; Marcus Neuffer; Shameema Sikder; Dane Church; Mark D Mifflin
Journal:  Clin Ophthalmol       Date:  2011-09-20

10.  Outcomes of Retreatment after Aborted Laser In Situ Keratomileusis due to Flap Complications.

Authors:  Hani S Al-Mezaine; Saleh A Al-Amro; Abdulaziz Al-Fadda; Saleh Al-Obeidan
Journal:  Middle East Afr J Ophthalmol       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.